Clover Health Investments Corp. Class A (CLOV)
NASDAQ: CLOVHealthcareHealthcare PlansUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 4.52 -0.88%
CLOV stock chart
Technical analysisKey statistics
All statistics- Market cap
- $2.42B
- Forward P/E
- 30.40
- EPS (TTM)
- -$0.05
- Dividend yield
- None
- 52-week range
- 1.58 – 5.59
- Day range
- 4.53 – 4.75
- Volume / Avg
- 7.40M / 4.27M
- Beta
- —
- Shares outstanding
- 435.44M
- Next earnings
- Nov 3, 2026
52-week range
CLOV stock today
On Oct 7, CLOV ended the session at $4.56, shedding $0.04 (0.87%), versus the S&P 500's 0.22% decline. At this level, CLOV sits in the middle of its 52-week range of $1.58 to $5.59: 18.4% below the high, set on Jun 29, 2026 and 188.6% above the low. CLOV is up 94.0% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 68.9%.
Clover Health Investments has posted a net loss over the last twelve months (EPS of -$0.05), so its P/E ratio is not meaningful. Clover Health Investments's next earnings report is expected on Nov 3, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Clover Health Investments
Company profileClover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- CEO
- Mr. Andrew Toy
- Headquarters
- Wilmington, DE
- Employees
- 724
- Website
- cloverhealth.com
Analyst forecast
ForecastConsensus (4 analysts)
none
Avg. price target
$5.38+17.98%
- Strong buy 0
- Buy 2
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 3, 2026
- EPS estimate
- $-0.01
CLOV news
All CLOV newsClover Health Investments peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PGNYProgyny Inc. | 27.55 | +6.33% | $2.11B | vs CLOV |
| ALHCAlignment Healthcare Inc. | 8.55 | +2.15% | $1.77B | vs CLOV |
| OSCROscar Health Inc. Class A | 32.91 | +1.76% | $10.16B | vs CLOV |
| MOHMolina Healthcare Inc | 194.82 | -0.18% | $10.17B | vs CLOV |
| CNCCentene Corporation | 64.99 | +0.59% | $32.10B | vs CLOV |
| HUMHumana Inc. | 396.51 | -1.92% | $47.61B | vs CLOV |
| CIThe Cigna Group | 278.51 | +1.51% | $73.59B | vs CLOV |
| ELVElevance Health Inc. | 404.31 | +1.05% | $87.68B | vs CLOV |
Indexes, lists and sector
Appears in lists
Clover Health Investments stock FAQ
What is Clover Health Investments's stock price today?
CLOV last traded at $4.56 as of Oct 7, 4:00 PM EDT, down 0.87% on the day. Prices are delayed at least 15 minutes.
When is Clover Health Investments's next earnings date?
Clover Health Investments is expected to report earnings on Tuesday, November 3, 2026. Analysts expect EPS of $-0.01.
Who is Clover Health Investments's CEO?
Mr. Andrew Toy is the chief executive officer of Clover Health Investments Corp. Class A, which has about 724 employees.
What is the CLOV 52-week high?
The 52-week high for CLOV is $5.59 and the 52-week low is $1.58. The stock is currently 18.4% below its high.